The final analysis including the 24-month evaluation of Xintela's (XINT) clinical study on XSTEM for knee osteoarthritis has now been completed. The results show continued safety, reduction of knee pa ...

An experimental medication made from marijuana successfully reduced back pain in a new study, offering further support for ...

The enteric nervous system (ENS), the largest division of autonomic nervous system, is a tantalizing frontier in neuroscience. With the advent of single-cell transcriptomics, the ENS has been ...

Duke University in North Carolina has launched an initiative to examine the opportunities and challenges that artificial ...

Indian REITs offer attractive yields, surpassing those in mature markets, making them appealing to investors. The real estate ...

The FDA re-approved Wellcovorin, a drug from GSK, that the company stopped selling more than 25 years ago, as part of a push from the Trump administration to identify the causes of and potential ...

On 15 September 2025, Regeneron Pharmaceuticals conducted a study is researching an experimental drug called REGN5381 (called ...

RedChip Companies will air interviews with BioVie Inc. (NASDAQ:BIVI) and FibroBiologics, Inc. (Nasdaq:FBLG) on the RedChip ...

Hansa Biopharma A/S has turned in positive data from a pivotal U.S. phase III trial of imlifidase, an enzyme that speedily removes antibodies from the bloodstream, enabling highly sensitized kidney ...

Are you prepared to live a longer and healthier life? Discover practical ways to improve wellness, extend longevity, and embrace habits that support vitality every day.

Days after Meagan Brazil-Sheehan’s 6-year-old son was diagnosed with leukemia, they were walking down the halls of UMass ...